The FDA approved Eli Lilly and Company’s osteoporosis drug, Evista, to reduce the risk of invasive breast cancer
On Sept. 14, 2007, the U.S. Food and Drug Administration (FDA) announced it had approved Eli Lilly’s osteoporosis…
On Sept. 14, 2007, the U.S. Food and Drug Administration (FDA) announced it had approved Eli Lilly’s osteoporosis…
In 2006, Texas Biomed researchers published a genetic linkage map for the rhesus monkey. In 1999, Texas Biomed…
Oct. 20, 1996, the United Kingdom’s National Osteoporosis Society supported by the European Commission, announced the creation of…